TY - JOUR
T1 - Evaluating the breast cancer quality of care indicators in Iran; multicenter study
AU - Rajabpour, Mojtaba Vand
AU - Seyyedsalehi, Monireh Sadat
AU - Nahvijou, Azin
AU - Nemati, Saeed
AU - Javanmard, Shaghayegh Haghjooy
AU - Manteghinejad, Amirreza
AU - Abdi, Sepideh
AU - Farazmand, Borna
AU - Pirnejad, Habibollah
AU - Sorkheh, Arash Golpazir
AU - Anasari, Jamshid
AU - Bahrami, Masoud
AU - Marzban, Maryam
AU - Ghoreishi, Seyedeh Masoumeh
AU - Nia, Yahya Baharvand Iran
AU - Bakhshi, Fataneh
AU - Ansari-Moghaddam, Alireza
AU - Binabaj, Maryam Moradi
AU - Nourmohammadi, Hassan
AU - Omranipour, Ramesh
AU - Abdollahi, Alireza
AU - Aghili, Mahdi
AU - Mohagheghi, Mohammad Ali
AU - Ghanbari-Motlagh, Ali
AU - Basu, Partha
AU - Boffetta, Paolo
AU - Zendehdel, Kazem
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/12
Y1 - 2025/12
N2 - Background: Data on quality-of-care indicators for breast cancer patients is limited in low—and middle-income countries. We evaluated the indicators in Iran. Method: A total of 21 quality-of-care indicators of breast cancer management defined by EUSOMA 2017 were selected. The indicators were retrospectively evaluated based on the data from the Clinical Breast Cancer Registry established in 11 provinces of Iran. Result: In the study of 6,293 patients evaluated on 21 indicators, 15 indicators were more than 5% below EUSOMA's standard levels. Conclusion: The defined indicators had a value lower than the suggested standards by EUSOMA. This study's results highlight important clues for intervention in improving breast cancer outcomes in Iran and other low—and middle-income countries.
AB - Background: Data on quality-of-care indicators for breast cancer patients is limited in low—and middle-income countries. We evaluated the indicators in Iran. Method: A total of 21 quality-of-care indicators of breast cancer management defined by EUSOMA 2017 were selected. The indicators were retrospectively evaluated based on the data from the Clinical Breast Cancer Registry established in 11 provinces of Iran. Result: In the study of 6,293 patients evaluated on 21 indicators, 15 indicators were more than 5% below EUSOMA's standard levels. Conclusion: The defined indicators had a value lower than the suggested standards by EUSOMA. This study's results highlight important clues for intervention in improving breast cancer outcomes in Iran and other low—and middle-income countries.
KW - Breast Neoplasm
KW - Countries
KW - Developing
KW - EUSOMA
KW - Healthcare
KW - Indicators
KW - Quality of Care
KW - System
UR - https://www.scopus.com/pages/publications/105005783533
U2 - 10.1186/s12885-025-14260-3
DO - 10.1186/s12885-025-14260-3
M3 - Article
C2 - 40410690
AN - SCOPUS:105005783533
SN - 1471-2407
VL - 25
JO - BMC Cancer
JF - BMC Cancer
IS - 1
M1 - 925
ER -